Drug Discovery in Cancer Epigenetics

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Science & Nature, Science, Biological Sciences, Genetics
Cover of the book Drug Discovery in Cancer Epigenetics by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128024928
Publisher: Elsevier Science Publication: November 19, 2015
Imprint: Academic Press Language: English
Author:
ISBN: 9780128024928
Publisher: Elsevier Science
Publication: November 19, 2015
Imprint: Academic Press
Language: English

Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.

  • Highlights the potential of epigenetic alterations in cancer for drug development
  • Covers the tools and methods for epigenetic drug discovery, preclinical and clinical testing, and clinical implications of epigenetic therapy
  • Provides important information regarding putative epigenetic targets, epigenetic technologies, networks and consortia for epigenetic drug discovery and routes for translation
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.

More books from Elsevier Science

Cover of the book Maintaining and Evolving Successful Commercial Web Sites by
Cover of the book Clinical Biochemistry of Domestic Animals by
Cover of the book Ghrelin by
Cover of the book The Mendip Caves by
Cover of the book Pulse Foods by
Cover of the book Additives for Plastics Handbook by
Cover of the book Ion Channels Down Under by
Cover of the book Advances in Immunology by
Cover of the book Self-Piercing Riveting by
Cover of the book Transaction Processing by
Cover of the book Cell Biology of the B Cell Receptor by
Cover of the book Intruder Alarms by
Cover of the book Handbook of Offshore Engineering (2-volume set) by
Cover of the book Windows Registry Forensics by
Cover of the book Handbook of Differential Equations: Ordinary Differential Equations by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy